IL319958A - Compositions and methods for modulating macrophage activity - Google Patents

Compositions and methods for modulating macrophage activity

Info

Publication number
IL319958A
IL319958A IL319958A IL31995825A IL319958A IL 319958 A IL319958 A IL 319958A IL 319958 A IL319958 A IL 319958A IL 31995825 A IL31995825 A IL 31995825A IL 319958 A IL319958 A IL 319958A
Authority
IL
Israel
Prior art keywords
modulation
compositions
methods
macrophage activity
macrophage
Prior art date
Application number
IL319958A
Other languages
English (en)
Hebrew (he)
Original Assignee
Macomics Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Macomics Ltd filed Critical Macomics Ltd
Priority claimed from PCT/GB2023/050592 external-priority patent/WO2023170434A1/en
Publication of IL319958A publication Critical patent/IL319958A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2803—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C07K2317/76—Antagonist effect on antigen, e.g. neutralization or inhibition of binding

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Genetics & Genomics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oncology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
IL319958A 2022-10-04 2023-03-13 Compositions and methods for modulating macrophage activity IL319958A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB2214614.6A GB202214614D0 (en) 2022-10-04 2022-10-04 Compositions and methods for modulation of macrophage
PCT/GB2023/050592 WO2023170434A1 (en) 2022-03-11 2023-03-13 Compositions and methods for modulation of macrophage activity

Publications (1)

Publication Number Publication Date
IL319958A true IL319958A (en) 2025-05-01

Family

ID=84000149

Family Applications (1)

Application Number Title Priority Date Filing Date
IL319958A IL319958A (en) 2022-10-04 2023-03-13 Compositions and methods for modulating macrophage activity

Country Status (8)

Country Link
JP (1) JP2025535192A (enExample)
KR (1) KR20250096720A (enExample)
CN (1) CN120435496A (enExample)
AU (1) AU2023232991A1 (enExample)
CR (1) CR20250172A (enExample)
GB (1) GB202214614D0 (enExample)
IL (1) IL319958A (enExample)
MX (1) MX2025003929A (enExample)

Also Published As

Publication number Publication date
JP2025535192A (ja) 2025-10-22
MX2025003929A (es) 2025-05-02
CR20250172A (es) 2025-09-04
AU2023232991A1 (en) 2025-04-10
CN120435496A (zh) 2025-08-05
KR20250096720A (ko) 2025-06-27
GB202214614D0 (en) 2022-11-16

Similar Documents

Publication Publication Date Title
SG11202105345TA (en) Compositions and methods of modulating short-chain dehydrogenase activity
IL309952A (en) Compositions and methods for treating melanoma
IL314320A (en) Compounds and methods of use
EP4172331A4 (en) METHODS AND COMPOSITIONS RELATED TO THE CATALYTIC ACTIVATION OF HUMAN ARGONAUTE-3
EP4329902A4 (en) DYNAMIC PLAYBACK OF CONTENT DURING AN EXERCISE ACTIVITY
IL307625A (en) Compounds and methods for modulating pnpla3 expression
IL318393A (en) Azaquinazoline compounds and methods of use
LT4192814T (lt) Transgliutaminazės inhibitoriai
GB202314084D0 (en) Compositions and methods for modulation of macrophage activity
IL319958A (en) Compositions and methods for modulating macrophage activity
GB202203384D0 (en) Compositions and Methods for Modulation of Macrophage Activity
GB202314086D0 (en) Compositions and method for modulation of macrophage activity
CA3269723A1 (en) Compositions and methods for modulation of macrophage activity
HK40119976A (en) Compositions and methods for modulation of macrophage activity
EP4291221A4 (en) METHODS AND COMPOSITIONS FOR MODULATING FGF ACTIVITY
EP4251272A4 (en) COMPOSITIONS AND METHODS FOR THE TREATMENT OF BLEEDING DISORDERS
IL309077A (en) Transglutaminase inhibitors
EP4302099A4 (en) COMPOSITIONS AND METHODS FOR MONITORING ENPP1 ACTIVITY
IL315878A (en) Compounds and Methods for Modulating SCAP Activity
CA3301250A1 (en) Compounds and compositions for modulating the activity of erk
HK40090089A (en) Compositions and methods of modulating short-chain dehydrogenase activity
HK40104120A (en) Methods and compositions for modulating car-t activity
HK40111951A (en) Compositions and methods for treatment of melanoma
CA3286796A1 (en) Compositions for modulation of il-2 and methods thereof
AU2024238641A1 (en) Compositions for modulation of il-2 and methods thereof